Navigation Links
PDC Biotech GmbH Announces Close of Series A Financing
Date:10/31/2009

VIENNA, AUSTRIA, October 30, 2009 / b3c newswire / - PDC Biotech GmbH (PDC) today announced the close of a Series A financing of over 4 million. MIG Verwaltungs AG (Munich) and Edmond de Rothschild Investment Partners (Paris) co-led the round.

Proceeds from the financing will be used to complete preclinical work and the first clinical study of the companys lead compound, PDC31 which is being developed for the treatment of preterm labour and primary dysmenorrhea. The company is expecting to conclude the remaining preclinical work early in mid 2010 and then conduct the Phase I/II trial.

PDC31 is a peptide antagonist of the prostaglandin F2a (FP) receptor, the lead in a series of FP antagonists exclusively licensed to PDC Biotech GmbH from Theratechnologies, (TSX: TH), a Canadian biopharmaceutical company.

Ms. Patricia Griffin and Ms Diane Kalina, co-founders of PDC stated: We are delighted to have such outstanding investors who understand the potential of our company and who are able to provide the necessary capital to advance our programs despite the difficult financing market.

The company was previously awarded 1 million in seed funding from the Austria Wirtschaftsservice (AWS) and a grant of 517,000 from the Zentrum fr Innovation und Technologie (ZIT; an agency of the City of Vienna for promotion of innovation and technology). The total funds raised since inception amount to over 5.56 million (approx. CDN $8.9 million).

Preterm Labour
Preterm labour is defined as regular uterine contractions associated with cervical changes occurring before 37 weeks of gestation. Preterm birth, which is associated with increased risk of neonatal m
'/>"/>

b3c newswire

0

GOOD

Page: 1 2 3

Related biology news :

1. Media source impacts ag biotech communication
2. KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification
3. GATC Biotech AG is investing more than 5 million euros in its Constance site to double the companys floor space
4. Anti-biotech groups obstruct forest biotechnology
5. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
6. Genome sequencing of fungus with biotechnological applications
7. Biotech scientists team with curators to stem decay of worlds art, cultural heritage
8. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
9. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
10. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics
11. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2009)... The Scripps Research Institute have solved a 10-year-old ... ancient family of enzymes can have two completely ... providing guidance for understanding other molecules in the ... the protein,s possible use for combating diseases including ... published in the December 13, 2009 advance, online ...
(Date:12/11/2009)... GETTYSBURG, PAAs consumer demand for premium fruit increases, ... fruit to market. And to boost their bottom ... that can increase fruit quality while reducing labor ... by growers to produce larger, healthier fruit, is ... a significant impact on fruit production overhead, and, ...
(Date:12/11/2009)... green plants photosynthesize, absorb carbon dioxide and produce ... that photosynthesis has had on Earth. One of ... evolution of photosynthesis is Jeffrey Touchman, assistant professor ... , Oxygen, one of the by-products of photosynthesis ... (including algae and higher plants), transformed the Precambrian ...
Breaking Biology News(10 mins):Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Horizontal string trimmer reduces labor costs, increases peach size 2'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 1Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 5Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 6Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 7Boys May Feel a Genetic Pull Toward Gangs 49195 1Boys May Feel a Genetic Pull Toward Gangs 49195 2New Anticoagulant Pill Works Well in Trial 49193 1New Anticoagulant Pill Works Well in Trial 49193 2New Anticoagulant Pill Works Well in Trial 49193 3
... accurately sense light governs everything from seed germination, photosynthesis ... Now, for the first time, scientists have obtained a ... detectors, a protein found in many species across life's ... structure of the protein known as phytochrome, scientists can ...
... , Chinese men are selectively switching from traditional ... dysfunction, but sticking with tradition for ailments such ... research published in Environmental Conservation. , The finding ... researchers at the advent of Viagra's commercial release ...
... and five million years ago, a massive swarm of ... and made an unlikely voyage across the Atlantic Ocean ... of researchers. , Using genetic evidence from more than ... Toronto, Arizona, Maryland, Cornell University and the U.S. Department ...
Other Biology News:Scientists map one of biology's critical light-sensing structures 2Scientists map one of biology's critical light-sensing structures 3Viagra's hidden help for wildlife 2Ancient trans-Atlantic swarm brought locusts to the New World 2
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... Scientific Corporation (NYSE: BSX ) today announced ... aggregate principal amount of its senior notes under the ... of $850 million of 4.50 percent notes due January ... 2020 and $300 million of 7.375 percent notes due ... net proceeds for general corporate purposes, including prepaying its ...
(Date:12/14/2009)... ThermoFab, a US-based thermoforming company, has completed the delivery of ... sheet metal to a plastic enclosure with a smaller footprint ... ... Shirley, MA (PRWEB) December 14, 2009 -- ThermoFab, a US-based ... Flow Tester – helping Brookfield move from sheet metal to ...
(Date:12/11/2009)... 10, 2009 miRagen Therapeutics, Inc., a biopharmaceutical ... innovative microRNA-based therapeutics for cardiovascular and muscle disease, ... microRNA-206 (miR-206) plays a crucial role in the ... Gehrig,s disease) and in neuromuscular synaptic regeneration in ... 11 issue of the journal Science , ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2
... have invented an affordable technique that uses lasers and ... needed for new generations of microchips. , The ... times narrower than a human hair, may enable the ... applications in medicine, optical communications, computing and sensor technologies. ...
... (Nasdaq: EXEL ) announced today that Frank Karbe, ... present at the,Piper Jaffray Europe Conference at 3:40 a.m. ... 25, 2008. Mr. Karbe will discuss updates,to the company,s ... be webcast and may be accessed in the Event,Calendar ...
... Germany is on the,cutting edge in biotechnology R&D and ... located in Germany are poised to,profit from the latest ... panel, at the BIO International Convention (BIO 2008),in San ... the,panel along with the CEO of a major transatlantic ...
Other Biology Technology:Trap and zap: Harnessing the power of light to pattern surfaces on the nanoscale 2Trap and zap: Harnessing the power of light to pattern surfaces on the nanoscale 3BIO 2008: Germany on Cutting Edge in Biomanufacturing 2
... Each glass slide in this set ... antibodies in triplicate, for a total ... house-keeping proteins as internal control. Antibodies ... as angiogenesis, apoptosis, cell cycle progression, ...
...
...
Kit for testing the ability of a compound to simulate lipolysis in cultured human adipocytes. Kit contains controls, buffers and reagents for detecting glycerol and non-esterified free fatty acids. A...
Biology Products: